Frequently navigating every stage of the capital raising process, including IPOs, follow-on offerings, and private placements, McDermott Will & Emery LLP showcases considerable strength in representing issuers. The practice is especially knowledgeable in PIPE transactions, skillfully leveraging its expertise in the advertising, gaming, and blockchain sectors. In Chicago, Eric Orsic co-heads the outfit, specializing in private securities transactions and secondary equity offerings, while the other lead in Washington DC Tom Conaghan is an expert in strategic investments. From New York, Bob Cohen focuses on bridge financings, and Dan Woodard is also cited as key.
L’éditorial du Legal 500
Distinctions
La satisfaction du client
Clients clés
- Accel Entertainment
- AdTheorent Holding Company, Inc.
- Aon plc
- Applied DNA Sciences, Inc.
- Esousa Holdings LLC
- Heritage-Crystal Clean, Inc.
- Inhibikase Therapeutics, Inc.
- Innovative International Acquisition
- Intensity Therapeutics, Inc.
- Interpace Biosciences
Points forts
- Represented investor Esousa Holdings LLC in a $150 million common stock equity line financing with Mullen Automotive.
- Represented REGENXBIO Inc. (NASDAQ: RGNX), a leading clinical- stage biotechnology company seeking to improve lives through the curative potential of gene therapy, as special regulatory counsel, in connection with an underwritten upsized public offering of 4,565,260 shares of its common stock at the price of $23.00 per share and 1,521,740 pre-funded warrants at a price of $22.9999 per warrant.
- Represented Tether International, the creator of USDT (the largest stablecoin by capitalization), in a private investment in public equity (PIPE) transaction involving the purchase of ordinary shares and warrants issued by Bidteer Technologies Group for a total purchase price of $100 million.
Avocats
Responsable de la pratique
Eric Orsic; Thomas Conaghan
Autres avocats clés
Bob Cohen; Heidi Steele; Dan Woodard; Richard Bass; Merrill Kraines; Todd Kornfeld